Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis

OBJECTIVE: To explore the safety and effectiveness of high-dose cyclophosphamide (HiCy) without bone marrow transplantation in patients with aggressive multiple sclerosis (MS). DESIGN: A 2-year open-label trial of patients with aggressive relapsing-remitting multiple sclerosis (RRMS) given an immuno...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Krishnan, Chitra, Kaplin, Adam I., Brodsky, Robert A., Drachman, Daniel B., Jones, Richard J., Pham, Dzung L., Richert, Nancy D., Pardo, Carlos A., Yousem, David M., Hammond, Edward, Quigg, Megan, Trecker, Carrilin, McArthur, Justin C., Nath, Avindra, Greenberg, Benjamin M., Calabresi, Peter A., Kerr, Douglas A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2008
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2574697/
https://ncbi.nlm.nih.gov/pubmed/18541787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.65.8.noc80042
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk